Dutch tech giant ASML posts bumper profits, eyes bright AI future

Weather - Sydney 18°C

Dutch tech giant ASML posts bumper profits, eyes bright AI future

ECONOMY 28.01.2026

Dutch tech giant ASML posts bumper profits, eyes bright AI future / Photo: © AFP

Dutch tech giant ASML, which sells cutting-edge machines to make semiconductor chips, reported a significant gain in annual net profit Wednesday and predicted a bright future driven by demand for artificial intelligence.

Change text size:

ASML is a critical cog in the global economy, as the semiconductors crafted with its tools power everything from smartphones to missiles.

After-tax profit for 2025 came in at 9.6 billion euros ($11.5 billion), compared with 7.6 billion euros for 2024.

"In the last months, many of our customers have shared a notably more positive assessment of the medium-term market situation, primarily based on more robust expectations of the sustainability of AI-related demand," CEO Christophe Fouquet said in a statement.

Fourth quarter net bookings, the figure traders track most closely, came in at 13.2 billion euros.

This compared with 5.4 billion euros in the third quarter of 2024 and is likely to move the market as investors watch for signs of future performance.

Total 2025 net sales were a record 32.7 billion euros. The firm had previously said it did not expect sales to be below the 28.3 billion euros banked last year.

ASML expects net sales in 2026 to be between 34 and 39 billion euros, it announced in new forecasts.

For the first quarter of this year, the firm predicted it would post between 8.2 billion euros and 8.9 billion euros in sales.

"We expect 2026 to be another growth year for ASML's business," said Fouquet.

- US-China tech war -

The tech giant is caught in the middle of a US-led effort to curb high-tech exports to China over fears they could be used to bolster the country's military.

Beijing has been infuriated by the export curbs, describing them as "technological terrorism."

In a case unrelated to ASML, the Dutch government briefly seized control of Nexperia, a Chinese-owned company that makes low-tech semiconductors.

That move sparked a major row between Beijing and the West that threatened to cripple car manufacturers that rely on Nexperia chips.

In late October, following trade talks between China's President Xi Jinping and his US counterpart Donald Trump, Beijing agreed to resume exports of Nexperia chips halted over the row.

ASML already warned when presenting third-quarter results that China sales would "decline significantly" in 2026 compared with "very strong business" in 2024 and 2025.

Longer-term, ASML believes that the rapidly expanding AI market will push up its annual sales to between 44 billion and 60 billion euros by 2030.

Turning to the fourth quarter, ASML sales came in at 9.7 billion euros. It had forecast between 9.2 billion and 9.8 billion euros.

Net profit for the fourth quarter was 2.8 billion euros, compared to the 2.1 billion euros booked in the third quarter of last year.

P.Sinclair--TNT

Featured

Carney touts Canada 'pivot' away from US as Trump levels new threat

Canadian Prime Minister Mark Carney said Tuesday that reducing economic ties with the United States would come at a cost but the benefits were clear, as President Donald Trump threatened new penalties targeting Canada.

Nearly 1,100 flights cancelled after UK air traffic control glitch

Almost 1,100 flights to and from UK airports were cancelled Tuesday due to what the country's air traffic control service called a technical issue, in the latest glitch to spark travel chaos.

Carney touts Canada 'pivot' away from US as tariffs rise

Canadian Prime Minister Mark Carney on Tuesday said reducing economic ties with the United States would come at a cost but the long-term benefits were clear, as retaliatory tariffs on US products took effect.

The "Everlasting Battery" Inside Your Joints:UConn Professor's Self-Powered Healing Material just Got Acquired

A material that turns your own movement into medicine has just landed a corporate home. PetVivo Holdings (OTCQX: PETV), a veterinary biotech and biomedical device company focused on treating osteoarthritis in dogs and horses, has acquired PiezoBioMembrane (PBM) — a startup built around a biodegradable implant that generates electricity from the everyday force of a joint in motion, and uses that charge to help regrow cartilage from the inside out. The material is the invention of Thanh Nguyen, a professor of mechanical engineering in UConn's College of Engineering, who founded PBM in 2021 to advance new implementation methods for his work with piezoelectric materials — substances that convert mechanical force into electrical energy. These materials are typically ceramics: hard, brittle, and poorly suited for medical use. But Nguyen's lab developed new forms that are so , flexible, and biodegradable, breaking down naturally within the body over time. wound healing, The materials have already shown strong potential across a range of medical applications, including tissue regeneration, implanted force sensors, and targeted drug delivery in tumor treatment. How It Works biodegradable ultrasound for In the case of arthritis, Nguyen explains, the piezoelectric materials function as an off-the-shelf product that can be implanted or injected directly into the ailing joint — with no drugs, chemicals, or cells required. The everyday force exerted on the joint generates a small electrical charge, which helps regrow healthy cartilage, mimicking the body's natural use of electricity to regenerate tissue. "The body can be electrically stimulated to regrow," Nguyen says. PBM's materials "act like a battery — an everlasting battery that works whenever there is a force applied, and vanishes safely inside the body over time." PetVivo's Vision for the Acquisition PetVivo Holdings CEO John Lai expressed enthusiasm for the merger's potential to improve the lives of companion animals globally. "PBM has developed a compelling functional biomaterials platform with the potential to support the development of multiple medical device and therapeutic product lines across both human and animal health markets," Lai said in a press release. "By combining PBM's scientific innovation with PetVivo's product development capabilities, commercialization experience, regulatory expertise, and public company infrastructure, we believe we can accelerate theadvancement of technologies that may serve as the foundation for numerous future products and strategic opportunities." For Nguyen, the deal is a chance to scale technology that could eventually benefit both animals and people. "PetVivo is an animal health company, but they do have a big passion: pushing the technology towards clinical trials for human use," Nguyen says. "That aligned perfectly with my passion for developing technology that has an impact on human life. That is why I am excited about this merger, which facilitates my passion." A Track Record of Innovation Nguyen's research sits at the intersection of medicine, micro/nanotechnology, and biomaterials. His inventions have earned him publications in prominent scientific journals and media coverage from outlets including NPR. Nguyen founded PBM during the COVID-19 pandemic, a er realizing the material he had developed could be used to create an especially effective, biodegradable face mask — one where the mechanical force of breathing generated an electrical charge that provided an extra layer of protection against viruses. PBM is not Nguyen's only venture in the acquisition pipeline. His other startup, Single-Time Microneedles (STM), is also currently undergoing an acquisition process. STM has pioneered stable, efficient vaccine delivery technology in the form of an adhesive patch. shelfNguyen's focus on biodegradable materials has translated into a remarkably diverse range of medical applications. He has received five R01 grants from the National Institutes of Health (NIH) supporting research in cartilage regeneration, bone regeneration, HIV antibody delivery systems, and biodegradable ultrasound technology to boost the effectiveness of chemotherapy for brain cancer. "Whatever we are working on, we want to show that it works very well in vitro and in vivo," Nguyen says. "Then, when we are at the point of commercialization, we set up a startup or license the technology — or maybe team up with an industry partner." Thanh Nguyen is a professor of mechanical engineering in UConn's College of Engineering. (Courtesy of Thanh Nguyen

Change text size:

The National Times - Dutch tech giant ASML posts bumper profits, eyes bright AI future